Pantobex
( Pantoprazole Tablet )
Pantobex® contains Pantoprazole in delayed release tablet form. Pantoprazole is chemically a novel substituted benzimidazole derivative, which suppresses the final step in gastric acid production by forming a covalent bond to two sites of H +- K+ ATPase system at the secretory surface of the gastric parietal cell. This leads to inhibition of both basal and stimulated gastric effect that persists longer than 24 hours. Pantoprazole is quantitatively absorbed and its bioavailability does not change up on multiple dosing. Pantobex® is indicated in the Peptic ulcer diseases, Gastroesophageal reflux diseases(GERD), ulcers induced by the NSAIDs.
-
Powerful & consistent healer of PUD
- Significant clinical success rate in duodenal & gastric ulcer
- Successful in relieving GERD symptoms
- Successful in maintenance therapy
- Lowest potential for drug interaction among all the PPIs
- Most gastro-specific among all the PPIs
